GITR Intrinsically Sustains Early Type 1 and Late Follicular Helper CD4 T Cell Accumulation to Control a Chronic Viral Infection

PLoS Pathogens

Volumn 11, Issue 1, 2015, Pages 1-21

  Clouthier, Derek L ^a   Zhou, Angela C ^a   Wortzman, Michael E ^a   Luft, Olga ^a,b   Levy, Gary A ^a,b   Watts, Tania H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 2; PROTEIN S6; TETRAMER; TNFRSF18 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; OVARY FOLLICLE CELL; PROTEIN PHOSPHORYLATION; TH1 CELL; VIRUS INFECTION; VIRUS LOAD; ANIMAL; C57BL MOUSE; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CHRONIC DISEASE; CYTOLOGY; FEMALE; GENETICS; HAMSTER; HELPER CELL; HUMORAL IMMUNITY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOPOIESIS; MALE; PHYSIOLOGY;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

ANIMALS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CHRONIC DISEASE; CRICETINAE; FEMALE; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; IMMUNITY, HUMORAL; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOPOIESIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, HELPER-INDUCER; VIRUS DISEASES;

EID: 84923849317     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004517     Document Type: Article

References (50)

1. Ng CT, Snell LM, Brooks DG, Oldstone MB, (2013) Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe 13: 652–664. doi: 10.1016/j.chom.2013.05.014 23768490
2. Wherry EJ, (2011) T cell exhaustion. Nature Immunology 131: 492–499. doi: 10.1038/ni.2035
3. Virgin HW, Wherry EJ, Ahmed R, (2009) Redefining chronic viral infection. Cell 138: 30–50. doi: 10.1016/j.cell.2009.06.036
4. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682–687. doi: 10.1038/nature04444 16382236
5. Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, et al. (2010) Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 107: 14733–14738. doi: 10.1073/pnas.1009731107 20679213
6. Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, et al. (2008) Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 205: 2763–2779. doi: 10.1084/jem.20081398 19001139
7. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12: 1301–1309. doi: 10.1038/nm1492 17041596
8. Wang C, McPherson AJ, Jones RB, Kawamura KS, Lin GH, et al. (2012) Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection. J Exp Med 209: 77–91. doi: 10.1084/jem.20110675 22184633
9. Boettler T, Moeckel F, Cheng Y, Heeg M, Salek-Ardakani S, et al. (2012) OX40 facilitates control of a persistent virus infection. PLoS Pathog 8: e1002913. doi: 10.1371/journal.ppat.1002913 22969431
10. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, et al. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670–684. doi: 10.1016/j.immuni.2007.09.006 17950003
11. Matloubian M, Concepcion RJ, Ahmed R, (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68: 8056–8063. 7966595
12. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, et al. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188: 2205–2213. doi: 10.1084/jem.188.12.2205 9858507
13. Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, et al. (1994) Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol 68: 4700–4704. 7911534
14. Moir S, Chun TW, Fauci AS, (2011) Pathogenic mechanisms of HIV disease. Annu Rev Pathol 6: 223–248. doi: 10.1146/annurev-pathol-011110-130254 21034222
15. Arens R, Tesselaar K, Baars PA, van Schijndel GM, Hendriks J, et al. (2001) Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 15: 801–812. doi: 10.1016/S1074-7613(01)00236-9 11728341
16. De Milito A, Morch C, Sonnerborg A, Chiodi F, (2001) Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 15: 957–964. doi: 10.1097/00002030-200105250-00003 11399977
17. Matter M, Odermatt B, Yagita H, Nuoffer JM, Ochsenbein AF, (2006) Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med 203: 2145–2155. doi: 10.1084/jem.20060651 16923852
18. Tesselaar K, Arens R, van Schijndel GM, Baars PA, van der Valk MA, et al. (2003) Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol 4: 49–54. doi: 10.1038/ni869 12469117
19. Clouthier DL, Watts TH, (2014) Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection. Cytokine Growth Factor Rev 25: 91–106. doi: 10.1016/j.cytogfr.2013.12.003 24484736
20. Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, et al. (2004) Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 173: 5008–5020. doi: 10.4049/jimmunol.173.8.5008 15470044
21. van Olffen RW, Koning N, van Gisbergen KP, Wensveen FM, Hoek RM, et al. (2009) GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J Immunol 182: 7490–7500. doi: 10.4049/jimmunol.0802751 19494272
22. Shevach EM, Stephens GL, (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 6: 613–618. doi: 10.1038/nri1867 16868552
23. Ephrem A, Epstein AL, Stephens GL, Thornton AM, Glass D, et al. (2013) Modulation of Treg cells/T effector function by GITR signaling is context-dependent. Eur J Immunol 43: 2421–2429. doi: 10.1002/eji.201343451 23722868
24. Ronchetti S, Nocentini G, Riccardi C, Pandolfi PP, (2002) Role of GITR in activation response of T lymphocytes. Blood 100: 350–352. doi: 10.1182/blood-2001-12-0276 12070049
25. Ahmed R, Oldstone MB, (1988) Organ-specific selection of viral variants during chronic infection. J Exp Med 167: 1719–1724. doi: 10.1084/jem.167.5.1719 3367096
26. Snell LM, McPherson AJ, Lin GH, Sakaguchi S, Pandolfi PP, et al. (2010) CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection. J Immunol 185: 7223–7234. doi: 10.4049/jimmunol.1001912 21076066
27. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM, (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559–561. doi: 10.1038/342559a0 2573841
28. Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, et al. (2003) Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 9: 540–547. doi: 10.1038/nm866 12692546
29. West EE, Jin HT, Rasheed AU, Penaloza-Macmaster P, Ha SJ, et al. (2013) PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J Clin Invest 123: 2604–2615. doi: 10.1172/JCI67008 23676462
30. Bachmann MF, Wolint P, Walton S, Schwarz K, Oxenius A, (2007) Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Eur J Immunol 37: 1502–1512. doi: 10.1002/eji.200637023 17492805
31. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R, (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77: 4911–4927. doi: 10.1128/JVI.77.8.4911-4927.2003 12663797
32. Fahey LM, Wilson EB, Elsaesser H, Fistonich CD, McGavern DB, et al. (2011) Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med 208: 987–999. doi: 10.1084/jem.20101773 21536743
33. Crotty S, (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29: 621–663. doi: 10.1146/annurev-immunol-031210-101400 21314428
34. Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H, (1998) Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur J Immunol 28: 390–400. doi: 10.1002/(SICI)1521-4141(199801)28:01%3C390::AID-IMMU390%3E3.3.CO;2-F 9485218
35. Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, et al. (2011) Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med 17: 975–982. doi: 10.1038/nm.2425 21785433
36. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, et al. (2011) Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 17: 983–988. doi: 10.1038/nm.2426 21785430
37. So T, Croft M, (2013) Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules. Front Immunol 4: 139. doi: 10.3389/fimmu.2013.00139 23760533
38. Han JM, Patterson SJ, Levings MK, (2012) The Role of the PI3K Signaling Pathway in CD4(+) T Cell Differentiation and Function. Front Immunol 3: 245. doi: 10.3389/fimmu.2012.00245 22905034
39. Chen C, Edelstein LC, Gelinas C, (2000) The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20: 2687–2695. doi: 10.1128/MCB.20.8.2687-2695.2000 10733571
40. Chi H, (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol 12: 325–338. doi: 10.1038/nri3198 22517423
41. Esparza EM, Arch RH, (2005) Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation. J Immunol 174: 7869–7874. doi: 10.4049/jimmunol.174.12.7869 15944292
42. Kanamaru F, Youngnak P, Hashiguchi M, Nishioka T, Takahashi T, et al. (2004) Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J Immunol 172: 7306–7314. doi: 10.4049/jimmunol.172.12.7306 15187106
43. Ronchetti S, Nocentini G, Bianchini R, Krausz LT, Migliorati G, et al. (2007) Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells. J Immunol 179: 5916–5926. doi: 10.4049/jimmunol.179.9.5916 17947665
44. So T, Choi H, Croft M, (2011) OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling. J Immunol 186: 3547–3555. doi: 10.4049/jimmunol.1003156 21289304
45. Swain SL, McKinstry KK, Strutt TM, (2012) Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol 12: 136–148. doi: 10.1038/nri3152 22266691
46. Clouthier DL, Zhou AC, Watts TH, (2014) Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic LCMV thereby circumventing LCMV-induced downregulation of co-stimulatory GITRL on APC. J Immunol 193. doi: 10.4049/jimmunol.1401002 25281716
47. Aubert RD, Kamphorst AO, Sarkar S, Vezys V, Ha SJ, et al. (2011) Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection. Proc Natl Acad Sci U S A 108: 21182–21187. doi: 10.1073/pnas.1118450109 22160724
48. Teodorovic LS, Riccardi C, Torres RM, Pelanda R, (2012) Murine B cell development and antibody responses to model antigens are not impaired in the absence of the TNF receptor GITR. PLoS One 7: e31632. doi: 10.1371/journal.pone.0031632 22328941
49. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204: 57–63. doi: 10.1084/jem.20061852 17200412
50. von Herrath M, Whitton JL, (2001) Animal models using lymphocytic choriomeningitis virus. Curr Protoc Immunol Chapter 19: Unit 19 10. doi: 10.1002/0471142735.im1910s36